<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Caspase-8 (CASP8) and caspase-9 (CASP9) play crucial roles in regulating <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and their functional polymorphisms may alter <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="1" pm="."><plain>Our aim was to investigate the association between CASP8 and CASP9 gene polymorphisms and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) susceptibility </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A case-control study at 402 CRC patients and 480 healthy controls was undertaken in order to investigate the association between the genotype and allelic frequencies of CASP8 -652 6N ins/del and CASP9 -1263 A&gt;G polymorphisms and the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> susceptibility </plain></SENT>
<SENT sid="3" pm="."><plain>The polymerase chain reaction (PCR) restriction fragment length polymorphism method was used and the incidence of polymorphisms on <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> (<z:chebi fb="2" ids="33699">mRNA</z:chebi>) expression levels was detected by quantitative reverse-transcriptase PCR in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: No statistical significant association was observed between CASP8 -652 6N ins/del polymorphism frequencies and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> susceptibility </plain></SENT>
<SENT sid="5" pm="."><plain>CASP9 -1263 G allele was observed to be significant associated with reduced risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Homozygotes for the -1263 GG CASP9 genotype, and hetrozygotes for the -1263 AG genotype expressed 6.64- and 3.69-fold higher <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of Caspase-9, respectively compared to the -1263 AA genotype cases </plain></SENT>
<SENT sid="7" pm="."><plain>No significant association was observed between CASP9 -1263 A&gt;G polymorphism and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> characteristics </plain></SENT>
<SENT sid="8" pm="."><plain>The CASP9 -1263 GG genotype was associated with increased overall survival in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The CASP9 -1263 A&gt;G polymorphism was observed to play a protective role in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> predisposition, while the CASP9 -1263 GG genotype may confer a better prognosis at <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
</text></document>